Westport Innovations Inc. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Westport Innovations Inc. (a foreign private issuer) on September 15, 2010, covering the month of August 2010. The filing primarily serves to disclose a material business acquisition and associated financial schedules.
Key Financial Metrics
The filing text itself does not provide specific revenue, profit, cash flow, or debt figures for Westport Innovations Inc. for the current period. Instead, it references attached exhibits containing financial data for the acquired entity, OMVL S.P.A., including:
- Audited consolidated financial statements for the year ended December 31, 2009.
- Unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2010 and 2009.
- Unaudited pro forma condensed consolidated financial statements.
Specific numerical values for liquidity, margins, or debt are not present in the cover letter text and must be derived from the referenced exhibits.
Material Changes
The primary material change disclosed is the acquisition of OMVL S.P.A., detailed in the "Business Acquisitions Report" dated September 14, 2010 (Exhibit 99.1). This transaction represents a significant strategic shift for the registrant.
Guidance, Outlook, and Risks
The filing text does not contain explicit management commentary, forward-looking guidance, or a discussion of risks and contingencies. The focus is strictly on the regulatory disclosure of the acquisition and the provision of the target company's historical and pro forma financial data.
Investor Verification Checklist
- Review Exhibit 99.1 for the specific terms, purchase price, and strategic rationale of the OMVL S.P.A. acquisition.
- Analyze Exhibit 99.2 and 99.3 to assess the historical financial performance and current liquidity position of OMVL S.P.A.
- Examine Exhibit 99.4 to understand the pro forma impact of the acquisition on Westport Innovations Inc.'s consolidated financial position.
- Verify the integration timeline and any potential regulatory hurdles associated with the acquisition not detailed in the summary.